Liberty Wealth Management LLC Purchases 566 Shares of Clorox Co (NYSE:CLX)

Liberty Wealth Management LLC lifted its position in shares of Clorox Co (NYSE:CLX) by 14.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,615 shares of the company’s stock after purchasing an additional 566 shares during the period. Liberty Wealth Management LLC’s holdings in Clorox were worth $707,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Janus Henderson Group PLC raised its position in Clorox by 28.4% in the first quarter. Janus Henderson Group PLC now owns 1,771,185 shares of the company’s stock worth $284,204,000 after acquiring an additional 391,569 shares during the period. Geode Capital Management LLC raised its position in Clorox by 21.5% in the fourth quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock worth $292,347,000 after acquiring an additional 335,835 shares during the period. Martingale Asset Management L P raised its position in Clorox by 152.4% in the first quarter. Martingale Asset Management L P now owns 211,703 shares of the company’s stock worth $33,971,000 after acquiring an additional 127,816 shares during the period. PNC Financial Services Group Inc. raised its position in Clorox by 65.4% in the first quarter. PNC Financial Services Group Inc. now owns 299,966 shares of the company’s stock worth $48,133,000 after acquiring an additional 118,660 shares during the period. Finally, California Public Employees Retirement System raised its position in Clorox by 15.0% in the first quarter. California Public Employees Retirement System now owns 805,832 shares of the company’s stock worth $129,304,000 after acquiring an additional 104,896 shares during the period. 76.83% of the stock is currently owned by institutional investors.

CLX has been the topic of several research reports. Bank of America reaffirmed a “neutral” rating and issued a $154.00 price objective (down previously from $165.00) on shares of Clorox in a research report on Thursday, May 2nd. Argus lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Monday, May 20th. Wells Fargo & Co reissued a “hold” rating and issued a $153.00 price target on shares of Clorox in a research report on Thursday, August 1st. Citigroup set a $156.00 price target on shares of Clorox and gave the company a “hold” rating in a research report on Thursday, May 23rd. Finally, Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 price target on the stock in a research report on Monday, July 29th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company. Clorox presently has a consensus rating of “Hold” and a consensus price target of $154.07.

In related news, Director A D. David Mackay sold 3,400 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Diego J. Barral sold 1,987 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $157.59, for a total transaction of $313,131.33. The disclosure for this sale can be found here. In the last three months, insiders sold 25,786 shares of company stock worth $4,054,776. Insiders own 1.40% of the company’s stock.

NYSE CLX opened at $158.27 on Friday. The company has a 50 day simple moving average of $158.09. Clorox Co has a 12-month low of $139.26 and a 12-month high of $167.70. The company has a current ratio of 0.91, a quick ratio of 0.55 and a debt-to-equity ratio of 4.09. The company has a market capitalization of $20.08 billion, a price-to-earnings ratio of 25.04, a P/E/G ratio of 4.96 and a beta of 0.37.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The company had revenue of $1.63 billion for the quarter, compared to analyst estimates of $1.69 billion. During the same quarter in the previous year, the firm posted $1.66 earnings per share. The company’s quarterly revenue was down 3.8% compared to the same quarter last year. As a group, equities research analysts expect that Clorox Co will post 6.4 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Stockholders of record on Wednesday, July 31st will be given a $1.06 dividend. The ex-dividend date of this dividend is Tuesday, July 30th. This represents a $4.24 annualized dividend and a dividend yield of 2.68%. This is a positive change from Clorox’s previous quarterly dividend of $0.96. Clorox’s payout ratio is 67.09%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: What is the downside to momentum investing?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.